+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
SOLARA

Solara Active Pharma Sciences Share Price

₹739.15 +11.8 (1.62%)
Near 52W High of ₹774.00

25 Sep, 2026 3:52 PM (IST)

Solara Active Pharma Sciences live price: ₹739.15. It opened at ₹735 vs previous close ₹727; intraday high/low: ₹758/₹732. The 50 & 200 DMA stand at ₹637.50/₹571.60.

Solara Active Pharma Sciences Performance

  • Today's Low
  • ₹732
  • Today's High
  • ₹758
  • 52 Week Low
  • ₹422
  • 52 Week High
  • ₹774
  • Open Price₹735
  • Previous Close₹727
  • Volume304,985
  • 50 DMA₹637.50
  • 100 DMA₹595.90
  • 200 DMA₹571.60

Solara Active Pharma Sciences Chart

Investment Returns

  • Over 1 Month + 17.49%
  • Over 3 Month + 29.15%
  • Over 6 Month + 67.74%
  • Over 1 Year + 14.93%

Smart Investing Starts Here Start SIP with Solara Active Pharma Sciences for Steady Growth!

Invest Now

Solara Active Pharma Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -2192.7
  • PEG Ratio
  • 20.6
  • Market Cap Cr
  • 3,552
  • P/B Ratio
  • 2.8
  • Average True Range
  • 35.9
  • EPS
  • -0.3
  • Dividend Yield
  • 0
  • MACD Signal
  • 39.3
  • RSI
  • 65.68
  • MFI
  • 71.92

Latest Stock News Updates

Solara Active Pharma Sciences Ltd - 541540 - Closure of Trading Window

Intimation regarding Closure of Trading window for the quarter ended September 30, 2026

Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report

Solara Active Pharma Sciences Limited has informed the exchange regarding the Voting Results and the Scrutinizer''s report of the Ninth Annual General Meeting

Solara Active Pharma Sciences Ltd - 541540 - Shareholder Meeting / Postal Ballot-Outcome of AGM

Solara Active Pharma Sciences Limited has informed the Exchange regarding the Proceedings of Ninth Annual General Meeting held on September 18, 2026.

Solara Active Pharma Sciences Financials

Solara Active Pharma Sciences Technicals

EMA & SMA

Current Price
₹739.15
+ 11.8 (1.62%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹697.20
  • 50 Day
  • ₹637.50
  • 100 Day
  • ₹595.90
  • 200 Day
  • ₹571.60

Resistance and Support

743.02 Pivot Speed
  • R3 779.90
  • R2 768.90
  • R1 754.00
  • S1 728.10
  • S2 717.10
  • S3 702.20

Solara Active Pharma Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-07-23 Quarterly Results
2026-05-15 Audited Results
2026-03-24 Others Inter-alia, to consider 1. Making Second & Final Call on partly paid-up Equity Shares. 2. To fix the Record Date for the purpose of determining the eligible shareholders. 3. Other business matters.
2026-02-06 Quarterly Results
2025-11-05 Quarterly Results

Solara Active Pharma Sciences Shareholding Pattern

42.79%
41.93%
11.52%
2.79%
0.95%

About Solara Active Pharma Sciences

Solara Active Pharma Sciences is undertaking the business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of and dealing in active pharmaceutical ingredients. View More
  • NSE Symbol
  • SOLARA
  • BSE Symbol
  • 541540
  • Managing Director,Chief Executive Officer
  • Sandeep Rao
  • ISIN
  • INE624Z01016

Similar Stocks to Solara Active Pharma Sciences

Solara Active Pharma Sciences FAQs

Solara Active Pharma Sciences share price is ₹739 As on 26 September, 2026 | 00:16

The Market Cap of Solara Active Pharma Sciences is ₹3552.2 Cr As on 26 September, 2026 | 00:16

The P/E ratio of Solara Active Pharma Sciences is -2192.7 As on 26 September, 2026 | 00:16

The PB ratio of Solara Active Pharma Sciences is 2.8 As on 26 September, 2026 | 00:16

The 52 week High & Low of Solara Active Pharma Sciences is ₹774/₹422 respectively As on 26 September, 2026 | 00:16

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23